-
In a new article published in The Lancet, experts review the current field of Ebola vaccine candidates and clinical trials and highlight key gaps in knowledge that need to be addressed by future research. The [Read more] -
New research published in Cell Reports from scientists at the National Institute of Allergy and Infectious Diseases (NIAID) shows how Middle East respiratory syndrome coronavirus (MERS-CoV) can adapt to infect cells of a new species, [Read more] -
The Centers for Disease Control and Prevention (CDC) has partnered with the U.S. Department of Agriculture (USDA) and 4-H to develop “The Junior Disease Detectives: Operation Outbreak,” a graphic novel intended to educate youth audiences [Read more] -
To encourage the development and improvement of Infectious Diseases Next-Generation Sequencing (ID-NGS) analytical methods, precisionFDA – the community platform for NGS assay evaluation and regulatory science exploration – has launched the precisionFDA CDRH Infectious Disease [Read more] -
Recent findings from the Centers for Disease Control and Prevention reveal a staggering threefold increase in reported cases of vector-borne diseases between 2004 and 2016 in the United States. Making matters worse, nine new pathogens [Read more] -
Vaccinations have begun in a first-in-human trial of an experimental Zika virus vaccine, the National Institute of Allergy and Infectious Diseases (NIAID) announced today. The experimental vaccine, known as rZIKV/D4Δ30-713, was developed in NIAID’s Laboratory [Read more] -
See what we’re reading this week at Global Biodefense on topics including the difficulties of containing Ebola in a conflict zone, mining data to predict toxicological properties, and measles spreading to Brazil from the Venezuela crisis. POLICY [Read more]
